ArticleScientific reports2025
Bridging the gap: explainable ai for autism diagnosis and parental support with TabPFNMix and SHAP.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence for autism spectrum disorder: advances in diagnosis, behavior analysis and educational support.Frontiers in neuroscience · 2026Pooled it
- Nanomaterials for Alzheimer's disease: emerging strategies in diagnosis and therapy.Journal of nanobiotechnology · 2026Review
- Systemic inflammatory biomarkers (NLR, SII, PNI and FPR) combined with CEA for predicting advanced colorectal neoplasms: development and temporal validation of a machine learning model.Frontiers in oncology · 2026Article
Corrections and comments
- Retraction · 2025-12-05Computer-Aided Content or Computer-Generated Content · Concerns/Issues about Data · Concerns/Issues about Image · Concerns/Issues about Methods · Investigation by Journal/Publisher · Unreliable Results and/or Conclusions · · See also: https://pubpeer.com/publications/E1A0A9AC672336E92673154575091E
- Retracted
Authors and funding
1 author.
Funding
Abstract
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition that affects a growing number of individuals worldwide. Despite extensive research, the underlying causes of ASD remain largely unknown, with genetic predisposition, parental history, and environmental influences identified as potential risk factors. Diagnosing ASD remains challenging due to its highly variable presentation and overlap with other neurodevelopmental disorders. Early and accurate diagnosis is crucial for timely intervention, which can significantly improve developmental outcomes and parental support. This work presents a novel artificial intelligence (AI) and explainable AI (XAI)-based framework to enhance ASD diagnosis and provide interpretable insights for medical professionals and caregivers. The proposed framework leverages advanced classification models, specifically the TabPFNMix regressor, which is optimized for structured medical datasets. Unlike traditional machine learning methods, TabPFNMix demonstrates superior performance in capturing complex ASD-related patterns. To address the black-box nature of AI models, Shapley Additive Explanations (SHAP) is integrated to provide transparent and interpretable reasoning behind the model's decisions, ensuring better understanding for clinicians and caregivers. Extensive experiments were conducted using a publicly available benchmark dataset, with performance evaluated through standard metrics such as accuracy, precision, recall, F1-score, and AUC-ROC. Comparative analysis with baseline models, including Random Forest, XGBoost, Support Vector Machine (SVM), and Deep Neural Networks (DNNs), demonstrates that TabPFNMix achieves the highest accuracy (91.5%), surpassing XGBoost (87.3%) by 4.2 percentage points. Additionally, it attains superior recall (92.7%), precision (90.2%), F1-score (91.4%), and AUC-ROC (94.3%), ensuring both high diagnostic accuracy and robustness in real-world ASD screening. An ablation study highlights the significance of feature selection and preprocessing, revealing that omitting key features or preprocessing steps (such as normalization and missing data imputation) significantly degrades performance. Furthermore, SHAP-based feature importance analysis identifies social responsiveness scores, repetitive behavior scales, and parental age at birth as the most influential factors in ASD diagnosis. These insights align with medical literature, reinforcing the reliability of the model's predictions and its applicability in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.